Related Experiment Video
Updated: Jun 17, 2026
10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
miR-19 is a key oncogenic component of mir-17-92
Virginie Olive1, Margaux J Bennett, James C Walker
1Division of Cellular and Developmental Biology, Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94705, USA.
Genes & Development
|December 17, 2009
Summary
The mir-17-92 microRNA cluster promotes cancer. Researchers found miR-19 is the key oncogenic component, essential for driving B-cell lymphoma by inhibiting apoptosis and activating the Akt-mTOR pathway.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) play crucial roles in tumorigenesis.
- The mir-17-92 cluster, also known as Oncomir-1, is frequently amplified and overexpressed in B-cell lymphomas.
- mir-17-92 possesses an unusual structure, producing six distinct miRNAs from a single transcript.
Purpose of the Study:
- To functionally dissect the individual components of the mir-17-92 cluster.
- To determine the specific miRNA responsible for the oncogenic activity of mir-17-92 in vivo.
- To elucidate the molecular mechanisms by which mir-17-92 contributes to lymphomagenesis.
Main Methods:
- Utilized the Emu-myc mouse model of B-cell lymphoma.
- Assayed the tumorigenic potential of individual mir-17-92 components in vivo.
- Investigated the effects of miR-19 on apoptosis, Pten expression, and the Akt-mTOR pathway.
Main Results:
- Identified miR-19 as the critical oncogenic component of the mir-17-92 cluster.
- Demonstrated that miR-19 is both necessary and sufficient for promoting c-myc-induced lymphomagenesis.
- Showed that miR-19 represses apoptosis by inhibiting the tumor suppressor Pten, leading to Akt-mTOR pathway activation and enhanced cell survival.
Conclusions:
- miR-19 is the primary driver of the oncogenic activity attributed to the mir-17-92 cluster.
- The functional diversity among mir-17-92 components contributes to its multifaceted roles in tumorigenesis.
- Targeting miR-19 may offer a therapeutic strategy for B-cell lymphomas associated with mir-17-92 dysregulation.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...